Patents by Inventor CÉLINE LAURENCÉ

CÉLINE LAURENCÉ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHEMICAL MODEL OF A NEURODEGENERATIVE DISEASE, METHOD FOR PREPARATION AND USES OF SAME
    Publication number: 20170360964
    Abstract: The invention concerns the use of pyridinium furosemide or one of the derivatives, analogues, salts, metabolites, or prodrugs thereof in the preparation of a chemical model of a neurodegenerative disease, preferably Parkinson's disease. The invention also concerns the corresponding chemical model and the uses of same, in particular in screening tests for identifying drug candidates.
    Type: Application
    Filed: August 3, 2017
    Publication date: December 21, 2017
    Inventors: THIERRY MARTENS, MICHAEL RIVARD, CELINE LAURENCE, CHRISTOPHE MORIN, SONIA LEHRI-BOUFALA, NARIMANE ZEGHBIB
  • Chemical model of a neurodegenerative disease, method for preparation and uses of same
    Patent number: 9744250
    Abstract: The invention concerns the use of pyridinium furosemide or one of the derivatives, analogs, salts, metabolites, or prodrugs thereof in the preparation of a chemical model of a neurodegenerative disease, preferably Parkinson's disease. The invention also concerns the corresponding chemical model and the uses of same, in particular in screening tests for identifying drug candidates.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: August 29, 2017
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE
    Inventors: Thierry Martens, Michaël Rivard, Céline Laurencé, Christophe Morin, Sonia Lehri-Boufala, Narimane Zeghbib
  • CHEMICAL MODEL OF A NEURODEGENERATIVE DISEASE, METHOD FOR PREPARATION AND USES OF SAME
    Publication number: 20150328338
    Abstract: The invention concerns the use of pyridinium furosemide or one of the derivatives, analogues, salts, metabolites, or prodrugs thereof in the preparation of a chemical model of a neurodegenerative disease, preferably Parkinson's disease. The invention also concerns the corresponding chemical model and the uses of same, in particular in screening tests for identifying drug candidates.
    Type: Application
    Filed: November 19, 2013
    Publication date: November 19, 2015
    Inventors: THIERRY MARTENS, MICHAËL RIVARD, CÉLINE LAURENCÉ, CHRISTOPHE MORIN, SONIA LEHRI-BOUFALA, NARIMANE ZEGHBIB